Positive results from the MAESTRO-NASH OUTCOMES study could make resmetirom the first medication approved for patients with compensated NASH ...

Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases ...

Opinion: A tsunami of low-quality food into the American diet has been a disaster for kids' health. Let's put real food back in school lunches.

Talk about an organ-ic diet. Non-alcoholic fatty liver disease, the so-called “silent epidemic,” affects about one in four American adults. Getty Images/iStockphoto His latest roundup of ...

10/02/2024 October 2, 2024 Excess carbs are turned into fat by the liver, which can lead to fatty liver disease. Too much alcohol is a major cause, but a poor diet can also lead to this condition ...

A hepatologist is a liver doctor, a specialist who diagnoses and treats diseases related to the liver (hepatic disease). You may see a liver specialist for diseases including cirrhosis, fatty liver ...

MASLD, which was known until recently as nonalcoholic fatty liver disease, is estimated to affect nearly 4 in 10 people worldwide. It is the fastest-growing reason that people require liver ...

Non-Alcoholic Fatty Liver Diseases (NAFLD), which is now recognised as a major non-communicable disease, is emerging as an important cause of liver disease in India, warned the Union Health ...

The Union Health Ministry has introduced revised operational guidelines and a training module for Non-Alcoholic Fatty Liver Disease (NAFLD) to enhance patient care. NAFLD is a growing public ...

New Delhi, September 27 (IANS) The Union Health Ministry on Friday released the revised operational guidelines and training module for non-alcoholic fatty liver disease (NAFLD) -- which affects ...